{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AIDS", "HIV", "HIV reactivation", "HIV suppression", "natural products"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29226706", "DateCompleted": {"Year": "2019", "Month": "05", "Day": "20"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "01", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1089/AID.2017.0232"], "Journal": {"ISSN": "1931-8405", "JournalIssue": {"Volume": "34", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Jan"}}, "Title": "AIDS research and human retroviruses", "ISOAbbreviation": "AIDS Res Hum Retroviruses"}, "ArticleTitle": "Natural Products and HIV/AIDS.", "Pagination": {"StartPage": "31", "EndPage": "38", "MedlinePgn": "31-38"}, "Abstract": {"AbstractText": ["The study of natural products in biomedical research is not a modern concept. Many of the most successful medical therapeutics are derived from natural products, including those studied in the field of HIV/AIDS. Biomedical research has a rich history of discovery based on screens of medicinal herbs and traditional medicine practices. Compounds derived from natural products, which repress HIV and those that activate latent HIV, have been reported. It is important to remember the tradition in medical research to derive therapies based on these natural products and to overcome the negative perception of natural products as an \"alternative medicine.\""]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Medicine, University of California at San Francisco , San Francisco, California."}, {"Identifier": [], "Affiliation": "2 Department of Microbiology and Immunology, University of California at San Francisco , San Francisco, California."}], "LastName": "Cary", "ForeName": "Daniele C", "Initials": "DC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Medicine, University of California at San Francisco , San Francisco, California."}, {"Identifier": [], "Affiliation": "2 Department of Microbiology and Immunology, University of California at San Francisco , San Francisco, California."}], "LastName": "Peterlin", "ForeName": "B Matija", "Initials": "BM"}], "GrantList": [{"GrantID": "P30 AI027763", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01 AI125104", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "AIDS Res Hum Retroviruses", "NlmUniqueID": "8709376", "ISSNLinking": "0889-2229"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-HIV Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-HIV Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug therapy"], "DescriptorName": "HIV Infections"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Latency"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}], "CoiStatement": "No competing financial interests exist."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Society AC: Discovery and development of penicillin. www.acs.org/content/acs/en/education/whatischemistry/landmarks/flemingpenicillin.html Accessed July9, 2017"}, {"Citation": "Hare R: New light on the history of penicillin. Med Hist 1982;26:1\u201324", "ArticleIdList": ["PMC1139110", "7047933"]}, {"Citation": "Desborough MJR, Keeling DM: The aspirin story\u2014From willow to wonder drug. Br J Haematol 2017;177:674\u2013683", "ArticleIdList": ["28106908"]}, {"Citation": "Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, et al. : Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria. Malar J 2011;10:144.", "ArticleIdList": ["PMC3121651", "21609473"]}, {"Citation": "Landmarks: ACSNHC. Discovery of Camptothecin and Taxol\u00ae. www.acs.org/content/acs/en/education/whatischemistry/landmarks/camptothecintaxol.html Accessed July9, 2017"}, {"Citation": "Cragg GM: Paclitaxel (Taxol): A success story with valuable lessons for natural product drug discovery and development. Med Res Rev 1998;18:315\u2013331", "ArticleIdList": ["9735872"]}, {"Citation": "Dias DA, Urban S, Roessner U: A historical overview of natural products in drug discovery. Metabolites 2012;2:303\u2013336", "ArticleIdList": ["PMC3901206", "24957513"]}, {"Citation": "Su X-Z, Miller LH: The discovery of artemisinin and Nobel Prize in Physiology or Medicine. Sci China Life Sci 2015;58:1175\u20131179", "ArticleIdList": ["PMC4966551", "26481135"]}, {"Citation": "Tu Y: The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011;17:1217\u20131220", "ArticleIdList": ["21989013"]}, {"Citation": "Landmarks: ACSNHC. Discovery of ivermectin. www.acs.org/content/acs/en/education/whatischemistry/landmarks/ivermectin-mectizan.html Accessed July9, 2017"}, {"Citation": "UNAIDS: AIDS by the numbers 2015. Joint United Nations Programme on HIV/AIDS (UNAIDS) 2015"}, {"Citation": "Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al. : Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 1997;94:13193\u201313197", "ArticleIdList": ["PMC24285", "9371822"]}, {"Citation": "Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. : Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (New York, NY) 1997;278:1295\u20131300", "ArticleIdList": ["9360927"]}, {"Citation": "Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. : Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science (New York, NY) 1997;278:1291\u20131295", "ArticleIdList": ["9360926"]}, {"Citation": "Ho YC, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DI, et al. : Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 2013;155:540\u2013551", "ArticleIdList": ["PMC3896327", "24243014"]}, {"Citation": "Cary DC, Fujinaga K, Peterlin BM: Molecular mechanisms of HIV latency. J Clin Invest 2016;126:448\u2013454", "ArticleIdList": ["PMC4731164", "26731470"]}, {"Citation": "Kashman Y, Gustafson KR, Fuller RW, Cardellina JH, 2nd, McMahon JB, Currens MJ, et al. : The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 1992;35:2735\u20132743", "ArticleIdList": ["1379639"]}, {"Citation": "McKee TC, Covington CD, Fuller RW, Bokesch HR, Young S, Cardellina IJ, et al. : Pyranocoumarins from tropical species of the genus Calophyllum: A chemotaxonomic study of extracts in the National Cancer Institute collection. J Nat Prod 1998;61:1252\u20131256", "ArticleIdList": ["9784162"]}, {"Citation": "Newman RA, Chen W, Madden TL: Pharmaceutical properties of related calanolide compounds with activity against human immunodeficiency virus. J Pharm Sci 1998;87:1077\u20131080", "ArticleIdList": ["9724557"]}, {"Citation": "Creagh T, Ruckle JL, Tolbert DT, Giltner J, Eiznhamer DA, Dutta B, et al. : Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects. Antimicrob Agents Chemother 2001;45:1379\u20131386", "ArticleIdList": ["PMC90477", "11302799"]}, {"Citation": "Sonar VP, Corona A, Distinto S, Maccioni E, Meleddu R, Fois B, et al. : Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase. Eur J Med Chem 2017;130:248\u2013260", "ArticleIdList": ["28254698"]}, {"Citation": "Esposito F, Tintori C, Martini R, Christ F, Debyser Z, Ferrarese R, et al. : Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: Molecular modeling and biological evaluation. Chembiochem 2015;16:2507\u20132512", "ArticleIdList": ["26360521"]}, {"Citation": "Martini R, Esposito F, Corona A, Ferrarese R, Ceresola ER, Visconti L, et al. : Natural product Kuwanon-L inhibits HIV-1 replication through multiple target binding. Chembiochem 2017;18:374\u2013377", "ArticleIdList": ["27992102"]}, {"Citation": "Esposito F, Carli I, Del Vecchio C, Xu L, Corona A, Grandi N, et al. : Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication. Phytomedicine 2016;23:1383\u20131391", "ArticleIdList": ["27765358"]}, {"Citation": "Zhang HJ, Rumschlag-Booms E, Guan YF, Wang DY, Liu KL, Li WF, et al. : Potent inhibitor of drug-resistant HIV-1 strains identified from the medicinal plant Justicia gendarussa. J Nat Prod 2017;80:1798\u20131807", "ArticleIdList": ["28613071"]}, {"Citation": "Ma TC, Zhou RH, Wang X, Li JL, Sang M, Zhou L, et al. : Soybean-derived Bowman-Birk Inhibitor (BBI) inhibits HIV replication in macrophages. Sci Rep 2016;6:34752.", "ArticleIdList": ["PMC5062087", "27734899"]}, {"Citation": "Hashimoto F, Kashiwada Y, Cosentino LM, Chen CH, Garrett PE, Lee KH: Anti-AIDS agents\u2014XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. Bioorg Med Chem 1997;5:2133\u20132143", "ArticleIdList": ["9459011"]}, {"Citation": "Kashiwada Y, Hashimoto F, Cosentino LM, Chen CH, Garrett PE, Lee KH: Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J Med Chem 1996;39:1016\u20131017", "ArticleIdList": ["8676334"]}, {"Citation": "Smith PF, Ogundele A, Forrest A, Wilton J, Salzwedel K, Doto J, et al. : Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3\u2032,3\u2032-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection. Antimicrob Agents Chemother 2007;51:3574\u20133581", "ArticleIdList": ["PMC2043264", "17638699"]}, {"Citation": "Archin NM, Margolis DM: Emerging strategies to deplete the HIV reservoir. Curr Opin Infect Dis 2014;27:29\u201335", "ArticleIdList": ["PMC4031321", "24296585"]}, {"Citation": "Deeks SG: HIV: Shock and kill. Nature 2012;487:439\u2013440", "ArticleIdList": ["22836995"]}, {"Citation": "Pandelo Jose D, Bartholomeeusen K, da Cunha RD, Abreu CM, Glinski J, da Costa TB, et al. : Reactivation of latent HIV-1 by new semi-synthetic ingenol esters. Virology 2014;462\u2013463:328\u2013339", "ArticleIdList": ["PMC4383768", "25014309"]}, {"Citation": "Pak V, Eifler TT, Jager S, Krogan NJ, Fujinaga K, Peterlin BM. CDK11 in TREX/THOC Regulates HIV mRNA 3\u2032 End Processing. Cell host & microbe. 2015;18:560\u2013570", "ArticleIdList": ["PMC4648707", "26567509"]}, {"Citation": "Nabel G, Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987;326:711\u2013713", "ArticleIdList": ["3031512"]}, {"Citation": "Sedore SC, Byers SA, Biglione S, Price JP, Maury WJ, Price DH: Manipulation of P-TEFb control machinery by HIV: Recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR. Nucleic Acids Res 2007;35:4347\u20134358", "ArticleIdList": ["PMC1935001", "17576689"]}, {"Citation": "He N, Pezda AC, Zhou Q: Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation. Mol Cell Biol 2006;26:7068\u20137076", "ArticleIdList": ["PMC1592901", "16980611"]}, {"Citation": "Laird GM, Bullen CK, Rosenbloom DI, Martin AR, Hill AL, Durand CM, et al. : Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. J Clin Invest 2015;125:1901\u20131912", "ArticleIdList": ["PMC4463209", "25822022"]}, {"Citation": "Bullen CK, Laird GM, Durand CM, Siliciano JD, Siliciano RF: New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat Med 2014;20:425\u2013429", "ArticleIdList": ["PMC3981911", "24658076"]}, {"Citation": "Cary DC, Fujinaga K, Peterlin BM: Euphorbia kansui reactivates latent HIV. PLoS One 2016;11:e0168027.", "ArticleIdList": ["PMC5158021", "27977742"]}, {"Citation": "Bartholomeeusen K, Xiang Y, Fujinaga K, Peterlin BM: Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein. J Biol Chem 2012;287:36609\u201336616", "ArticleIdList": ["PMC3476326", "22952229"]}, {"Citation": "Bartholomeeusen K, Fujinaga K, Xiang Y, Peterlin BM: Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription. J Biol Chem 2013;288:14400\u201314407", "ArticleIdList": ["PMC3656295", "23539624"]}, {"Citation": "Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, et al. : An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. PLoS Pathog 2013;9:e1003834.", "ArticleIdList": ["PMC3873446", "24385908"]}, {"Citation": "Blazkova J, Chun TW, Belay BW, Murray D, Justement JS, Funk EK, et al. : Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy. J Infect Dis 2012;206:765\u2013769", "ArticleIdList": ["PMC3491743", "22732922"]}, {"Citation": "Jiang G, Mendes EA, Kaiser P, Wong DP, Tang Y, Cai I, et al. : Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation. PLoS Pathog 2015;11:e1005066.", "ArticleIdList": ["PMC4520526", "26225771"]}, {"Citation": "Cox PA, Johnson HE, Tavana G: Giving Samoan healers credit for prostratin. Science (New York, NY) 2008;320:1589", "ArticleIdList": ["18566269"]}, {"Citation": "Cox PA: Ensuring equitable benefits: The falealupo covenant and the isolation of anti-viral drug prostratin from a samoan medicinal plant. Pharm Biol 2001;39 Suppl 1:33\u201340", "ArticleIdList": ["21554169"]}, {"Citation": "Pettit GR, Kamano Y, Herald CL: Antineoplastic agents, 118. Isolation and structure of bryostatin 9. J Nat Prod 1986;49:661\u2013664", "ArticleIdList": ["3783162"]}, {"Citation": "Schrott LM, Jackson K, Yi P, Dietz F, Johnson GS, Basting TF, et al. : Acute oral Bryostatin-1 administration improves learning deficits in the APP/PS1 transgenic mouse model of Alzheimer's disease. Curr Alzheimer Res 2015;12:22\u201331", "ArticleIdList": ["25523423"]}, {"Citation": "Schaufelberger DE, Koleck MP, Beutler JA, Vatakis AM, Alvarado AB, Andrews P, et al. : The large-scale isolation of bryostatin 1 from Bugula neritina following current good manufacturing practices. J Nat Prod 1991;54:1265\u20131270", "ArticleIdList": ["1800630"]}, {"Citation": "Wang HY, Wang JS, Wei DD, Wang XB, Luo J, Yang MH, et al. : Bioactivity-guided isolation of antiproliferative diterpenoids from Euphorbia kansui. Phytotherapy research: PTR 2012;26:853\u2013859", "ArticleIdList": ["22095916"]}, {"Citation": "Shi QW, Su XH, Kiyota H: Chemical and pharmacological research of the plants in genus Euphorbia. Chem Rev 2008;108:4295\u20134327", "ArticleIdList": ["18817355"]}, {"Citation": "Kupchan SM, Uchida I, Branfman AR, Dailey RG, Jr., Fei BY: Antileukemic principles isolated from euphorbiaceae plants. Science (New York, NY) 1976;191:571\u2013572", "ArticleIdList": ["1251193"]}, {"Citation": "Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stough DB, et al. : Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. J Am Acad Dermatol 2009;60:934\u2013943", "ArticleIdList": ["19467365"]}, {"Citation": "Spivak AM, Bosque A, Balch AH, Smyth D, Martins L, Planelles V: Ex vivo bioactivity and HIV-1 latency reversal by ingenol dibenzoate and panobinostat in resting CD4+ T cells from aviremic patients. Antimicrob Agents Chemother 2015;59:5984\u20135991", "ArticleIdList": ["PMC4576101", "26169416"]}, {"Citation": "Perez M, de Vinuesa AG, Sanchez-Duffhues G, Marquez N, Bellido ML, Munoz-Fernandez MA, et al. : Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency. Curr HIV Res 2010;8:418\u2013429", "ArticleIdList": ["20636281"]}, {"Citation": "Korin YD, Brooks DG, Brown S, Korotzer A, Zack JA: Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J Virol 2002;76:8118\u20138123", "ArticleIdList": ["PMC155166", "12134017"]}, {"Citation": "Wang P, Lu P, Qu X, Shen Y, Zeng H, Zhu X, et al. : Reactivation of HIV-1 from latency by an ingenol derivative from Euphorbia kansui. Sci Rep 2017;7:9451.", "ArticleIdList": ["PMC5573388", "28842560"]}, {"Citation": "DeChristopher BA, Loy BA, Marsden MD, Schrier AJ, Zack JA, Wender PA: Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro. Nat Chem 2012;4:705\u2013710", "ArticleIdList": ["PMC3428736", "22914190"]}, {"Citation": "Marsden MD, Loy BA, Wu X, Ramirez CM, Schrier AJ, Murray D, et al. : In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell \u201ckick\u201d and \u201ckill\u201d in strategy for virus eradication. PLoS Pathog 2017;13:e1006575.", "ArticleIdList": ["PMC5608406", "28934369"]}, {"Citation": "Beans EJ, Fournogerakis D, Gauntlett C, Heumann LV, Kramer R, Marsden MD, et al. : Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo. Proc Natl Acad Sci U S A 2013;110:11698\u201311703", "ArticleIdList": ["PMC3718093", "23812750"]}, {"Citation": "Abreu CM, Price SL, Shirk EN, Cunha RD, Pianowski LF, Clements JE, et al. : Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: Inhibition of de novo infection and activation of viral LTR. PLoS One 2014;9:e97257.", "ArticleIdList": ["PMC4020785", "24827152"]}, {"Citation": "Jiang G, Mendes EA, Kaiser P, Sankaran-Walters S, Tang Y, Weber MG, et al. : Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cdelta-NF-kappaB signaling. AIDS (London, England) 2014;28:1555\u20131566", "ArticleIdList": ["PMC4922310", "24804860"]}, {"Citation": "Gama L, Abreu CM, Shirk EN, Price SL, Li M, Laird GM, et al. : Reactivation of SIV reservoirs in the brain of virally suppressed macaques. AIDS (London, England) 2017;31:5\u201314", "ArticleIdList": ["PMC5131686", "27898590"]}, {"Citation": "Gu XD, Zhang Q: Clinical progress in the treatment of severe acute pancreatitis with integrative Chinese and Western medicine. Chin J Integr Med 2007;13:235\u2013240", "ArticleIdList": ["17898960"]}, {"Citation": "Xing F, Tan Y, Yan GJ, Zhang JJ, Shi ZH, Tan SZ, et al. : Effects of Chinese herbal cataplasm Xiaozhang Tie on cirrhotic ascites. J Ethnopharmacol 2012;139:343\u2013349", "ArticleIdList": ["22107835"]}, {"Citation": "Bensky D, Clavey S, Stoger E: Chinese Herbal Medicine: Materia Medica, 3rd ed. Eastland Press, Vista, CA, 2004"}, {"Citation": "Hou JJ, Wu WY, Liang J, Yang Z, Long HL, Cai LY, et al. : A single, multi-faceted, enhanced strategy to quantify the chromatographically diverse constituents in the roots of Euphorbia kansui. J Pharm Biomed Anal 2014;88:321\u2013330", "ArticleIdList": ["24113191"]}, {"Citation": "Dutra RC, Claudino RF, Bento AF, Marcon R, Schmidt EC, Bouzon ZL, et al. : Preventive and therapeutic euphol treatment attenuates experimental colitis in mice. PLoS One 2011;6:e27122.", "ArticleIdList": ["PMC3206917", "22073270"]}, {"Citation": "ClinicalTrials.gov: Immunologic Response to Kansui in Treated HIV+ Individuals: A Dose Escalation Study. (2015). Retreived from https://clinicaltrials.gov/ct2/show/NCT02531295 (Id No: NCT02531295)"}, {"Citation": "De Rosso M, Panighel A, Vedova AD, Gardiman M, Flamini R: Characterization of non-anthocyanic flavonoids in some hybrid red grape extracts potentially interesting for industrial uses. Molecules (Basel, Switzerland) 2015;20:18095\u201318106", "ArticleIdList": ["PMC6332119", "26445038"]}, {"Citation": "Byun EB, Sung NY, Byun EH, Song DS, Kim JK, Park JH, et al. : The procyanidin trimer C1 inhibits LPS-induced MAPK and NF-kappaB signaling through TLR4 in macrophages. Int Immunopharmacol 2013;15:450\u2013456", "ArticleIdList": ["23261363"]}, {"Citation": "Sung NY, Yang MS, Song DS, Byun EB, Kim JK, Park JH, et al. : The procyanidin trimer C1 induces macrophage activation via NF-kappaB and MAPK pathways, leading to Th1 polarization in murine splenocytes. Eur J Pharmacol 2013;714:218\u2013228", "ArticleIdList": ["23770004"]}, {"Citation": "Hori T, Barnor J, Huu TN, Morinaga O, Hamano A, Ndzinu J, et al. : Procyanidin trimer C1 derived from Theobroma cacao reactivates latent human immunodeficiency virus type 1 provirus. Biochem Biophys Res Commun 2015;459:288\u2013293", "ArticleIdList": ["25727021"]}, {"Citation": "Khan N, Khymenets O, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, et al. : Cocoa polyphenols and inflammatory markers of cardiovascular disease. Nutrients 2014;6:844\u2013880", "ArticleIdList": ["PMC3942736", "24566441"]}, {"Citation": "Andujar I, Recio MC, Giner RM, Rios JL: Cocoa polyphenols and their potential benefits for human health. Oxid Med Cell Longev 2012;2012:906252.", "ArticleIdList": ["PMC3488419", "23150750"]}, {"Citation": "Wang C, Yang S, Lu H, You H, Ni M, Shan W, et al. : A natural product from Polygonum cuspidatum Sieb. Et Zucc. promotes Tat-dependent HIV latency reversal through triggering P-TEFb's release from 7SK snRNP. PLoS One 2015;10:e0142739.", "ArticleIdList": ["PMC4646521", "26569506"]}, {"Citation": "Wang Y, Jin F, Wang Q, Suo Z: Long-term survival of AIDS patients treated with only Traditional Chinese Medicine. AIDS Res Hum Retroviruses 2017;33:90\u201392", "ArticleIdList": ["PMC5312620", "28067535"]}, {"Citation": "Hope TJ: Can a Traditional Chinese Medicine contribute to a cure for HIV? AIDS Res Hum Retroviruses 2017;33:89.", "ArticleIdList": ["28170307"]}]}], "History": [{"Year": "2017", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29226706", "PMC5771529", "10.1089/AID.2017.0232"]}}]}